Mathias Riesbeck
- 3Articles
- 9.3KReads
- 2007–2011Active
- 29Collaborators
- 84Citations
About
Mathias Riesbeck has published research focused on schizophrenia and schizoaffective disorders, particularly examining treatment strategies for first-episode schizophrenia. His work includes studies on maintenance versus intermittent antipsychotic treatment, relapse prevention, and comparative effects of risperidone and low-dose haloperidol. Riesbeck has contributed to randomized controlled trials conducted within the German Research Network on Schizophrenia.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
